OverviewSuggest Edit

    MANREMYC is a “spin off” of the Institut for Biomedical Research Germans Trias i Pujol (IGTP) with the mission to eradicate tuberculosis (TB) by reducing its risk of development with a unique and revolutionary product, Nyaditum resae® (NR) based on the most updated technology and a solid scientific background.

    HQManresa, ES


    MANREMYC is headquartered in
    Manresa, Spain

    Location Map

    Latest Updates

    Employees (est.) (Sept 2020)7(+40%)
    Cybersecurity ratingBMore

    Key People/Management at MANREMYC

    PrPere-Joan Cardona

    PrPere-Joan Cardona

    Inventor of NR,Co-founder & CEO
    Isabel Amat

    Isabel Amat

    Cris Vilaplana

    Cris Vilaplana

    Co-Inventor of NR & Co-Founder
    Jaume Amat

    Jaume Amat

    Puig de Dou family

    Puig de Dou family

    Major Investors
    Carolina Rius

    Carolina Rius

    Social Investor
    Show more

    MANREMYC Office Locations

    MANREMYC has an office in Manresa
    Manresa, ES (HQ)
    Carrer d'Urgell, 26
    Show all (1)

    MANREMYC Financials and Metrics

    Summary Metrics

    Founding Date


    MANREMYC Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    MANREMYC Online and Social Media Presence

    Embed Graph

    MANREMYC Frequently Asked Questions

    • When was MANREMYC founded?

      MANREMYC was founded in 2013.

    • Who are MANREMYC key executives?

      MANREMYC's key executives are PrPere-Joan Cardona, Isabel Amat and Cris Vilaplana.

    • How many employees does MANREMYC have?

      MANREMYC has 7 employees.

    • Who are MANREMYC competitors?

      Competitors of MANREMYC include Opiant Pharmaceuticals, Mylan and Horizon Therapeutics.

    • Where is MANREMYC headquarters?

      MANREMYC headquarters is located at Carrer d'Urgell, 26, Manresa.

    • Where are MANREMYC offices?

      MANREMYC has an office in Manresa.

    • How many offices does MANREMYC have?

      MANREMYC has 1 office.